Dr. Nathan Stasko | CEO, Vast Therapeutics – Nitric Oxide Innovation in Respiratory Health
Update: 2025-09-04
Description
In this episode of Executive Insights for Life Sciences Innovators, we speak with Dr. Nathan Stasko, CEO of Vast Therapeutics, about the company’s journey with nitric oxide technology in respiratory therapeutics. Dr. Stasko shares the challenges of advancing novel drug delivery approaches, lessons learned in building a biotech startup, and his perspective on innovation in life sciences.
Learn more at genecoda.com.
This conversation was originally recorded and streamed on YouTube Live on July 10, 2025.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
